These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26929061)

  • 1. Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery.
    Voskoboinik A; Ihle JF; Bloom JE; Kaye DM
    Intern Med J; 2016 Jun; 46(6):723-7. PubMed ID: 26929061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Characteristics and Outcomes of Patients With Reversible Versus Persistent Methamphetamine-Associated Cardiomyopathy.
    Zhao SX; Seng S; Deluna A; Yu EC; Crawford MH
    Am J Cardiol; 2020 Jan; 125(1):127-134. PubMed ID: 31699360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.
    Schürer S; Klingel K; Sandri M; Majunke N; Besler C; Kandolf R; Lurz P; Luck M; Hertel P; Schuler G; Linke A; Mangner N
    JACC Heart Fail; 2017 Jun; 5(6):435-445. PubMed ID: 28571597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and predictors of normalization of left ventricular ejection fraction in recent-onset nonischemic cardiomyopathy.
    Zou CH; Zhang J; Zhang YH; Wei BQ; Wu XF; Zhou Q; Huang Y; Zhang RC; Lv R
    Am J Cardiol; 2014 May; 113(10):1705-10. PubMed ID: 24792739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse Takotsubo Cardiomyopathy and Cardiogenic Shock Associated With Methamphetamine Consumption.
    Chehab O; Ioannou A; Sawhney A; Rice A; Dubrey S
    J Emerg Med; 2017 Nov; 53(5):e81-e83. PubMed ID: 28916123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of left ventricular twist mechanics in Tako-tsubo cardiomyopathy by two-dimensional speckle-tracking echocardiography.
    Meimoun P; Passos P; Benali T; Boulanger J; Elmkies F; Zemir H; Clerc J; Luycx-Bore A
    Eur J Echocardiogr; 2011 Dec; 12(12):931-9. PubMed ID: 21965053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular myocardial performance index derived from tissue Doppler echocardiography is useful in differentiating apical ballooning syndrome from cardiomyopathy due to left anterior descending coronary artery disease.
    Bhat PK; Khan I; Finkelhor RS; Bahler RC; Rovner AL
    J Am Soc Echocardiogr; 2014 Jan; 27(1):101-6. PubMed ID: 24120319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
    Reddy PK; Chau E; Patel SV; Yang K; Ng TM; Elkayam U
    Am J Cardiol; 2021 Sep; 154():86-91. PubMed ID: 34233837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imaging.
    Ahtarovski KA; Iversen KK; Christensen TE; Andersson H; Grande P; Holmvang L; Bang L; Hasbak P; Lønborg JT; Madsen PL; Engstrøm T; Vejlstrup NG
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):855-62. PubMed ID: 24525137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial evaluation of microcirculatory dysfunction in patients with Takotsubo cardiomyopathy by myocardial contrast echocardiography.
    Jain M; Upadaya S; Zarich SW
    Clin Cardiol; 2013 Sep; 36(9):531-4. PubMed ID: 23797947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy.
    Moore JP; Patel PA; Shannon KM; Albers EL; Salerno JC; Stein MA; Stephenson EA; Mohan S; Shah MJ; Asakai H; Pflaumer A; Czosek RJ; Everitt MD; Garnreiter JM; McCanta AC; Papez AL; Escudero C; Sanatani S; Cain NB; Kannankeril PJ; Bratincsak A; Mandapati R; Silva JN; Knecht KR; Balaji S
    Heart Rhythm; 2014 Jul; 11(7):1163-9. PubMed ID: 24751393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction.
    Bhat PK; Ashwath ML; Rosenbaum DS; Costantini O
    Am J Cardiol; 2012 Jul; 110(1):83-7. PubMed ID: 22551737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of ventricular recovery in Takotsubo syndrome using stress and contrast echocardiography.
    Uznańska B; Plewka M; Wierzbowska-Drabik K; Chrzanowski Ł; Kasprzak JD
    Med Sci Monit; 2009 Jun; 15(6):CS89-94. PubMed ID: 19478706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation.
    Ling LH; Kalman JM; Ellims AH; Iles LM; Medi C; Sherratt C; Kaye DM; Hare JL; Kistler PM; Taylor AJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):697-704. PubMed ID: 23884195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time myocardial contrast echocardiography can predict functional recovery and left ventricular remodeling after revascularization in patients with ischemic heart disease.
    Zeng X; Shu XH; Pan CZ; Li Q; Guo SZ; Liu SZ; Chen HZ
    Chin Med J (Engl); 2007 Nov; 120(21):1890-3. PubMed ID: 18067761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.